Costly clots common in cancer
As many as 1 in 5 people risk developing a venous thromboembolism (VTE) within a year after undergoing treatment for some types of cancers, researchers reported.
Diagnosis & Disease Information
Oncology Nurse Advisor Forum – March/April 2011
The Advisor Forum panel answers nurses’ questions about patient care, treatment regimens, and oncology nursing.
Risk of venous thromboembolism
Treating patients with the recombinant monoclonal antibody bevacizumab carries a significant risk of venous thromboembolism (VTE), a meta-analysis has shown.
- Loading...
Loading...
Loading... 
Loading...